Related Experiment Video
Updated: Oct 16, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Coagulase-negative staphylococci resistant to beta-lactam antibiotics in vivo produce penicillin-binding protein 2a
1Medical Service, San Francisco General Hospital, California 94110.
Abstract:
Strains of coagulase-negative staphylococci were tested for in vivo resistance in a rabbit model of prophylaxis of endocarditis. Regimens of nafcillin, cefazolin, cefamandole, and vancomycin were compared for efficacy in the prevention of infection caused by two methicillin-resistant strains and a susceptible strain. For the two resistant strains, vancomycin was the most effective drug tested. All regimens were effective against the susceptible strain. The two strains for which prophylaxis with beta-lactam antibiotics failed produced a beta-lactam antibiotic-inducible penicillin-binding protein (PBP) that comigrated in sodium dodecyl sulfate-polyacrylamide gels with the low-affinity PBP 2a that is associated with methicillin resistance in strains of Staphylococcus aureus. Like PBP 2a, this PBP had low binding affinity for beta-lactam antibiotics. Peptide maps after either V8 protease or chymotrypsin digestion of radiolabeled PBP 2a or silver-stained preparations were virtually identical to one another and to maps of PBP 2a from a heterogeneous and a homogeneous strain of S. aureus. Methicillin resistance in coagulase-negative staphylococci and therapeutic failure with beta-lactam antibiotics in vivo is associated with production of PBP 2a, which appears to be highly conserved structurally among different species of staphylococci.
Insights
Vancomycin effectively treated infections from methicillin-resistant coagulase-negative staphylococci in rabbits. Beta-lactam antibiotic failure in these resistant strains was linked to a conserved penicillin-binding protein (PBP) 2a.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Coagulase-negative staphylococci (CoNS) are significant pathogens, particularly in healthcare settings.
- Antibiotic resistance in CoNS, especially methicillin resistance, poses a therapeutic challenge.
- Endocarditis prophylaxis models are crucial for evaluating antibiotic efficacy.
Purpose of the Study:
- To assess the in vivo efficacy of various antibiotics for endocarditis prophylaxis against CoNS.
- To investigate the mechanism of beta-lactam antibiotic resistance in CoNS.
- To compare the effectiveness of nafcillin, cefazolin, cefamandole, and vancomycin.
Main Methods:
- A rabbit model of endocarditis prophylaxis was employed.
- Antibiotic regimens included nafcillin, cefazolin, cefamandole, and vancomycin.
- Infection prevention was tested against two methicillin-resistant CoNS strains and one susceptible strain.
- Penicillin-binding protein (PBP) analysis was performed using SDS-PAGE and peptide mapping.
Main Results:
- Vancomycin demonstrated the highest efficacy against the two methicillin-resistant CoNS strains.
- All tested antibiotic regimens were effective against the susceptible CoNS strain.
- Resistant strains producing a specific PBP (penicillin-binding protein 2a) showed failure with beta-lactam antibiotics.
- This inducible PBP 2a exhibited low affinity for beta-lactam antibiotics and was structurally conserved.
Conclusions:
- Vancomycin is a viable option for prophylaxis against methicillin-resistant CoNS endocarditis.
- The production of PBP 2a is associated with beta-lactam antibiotic resistance and therapeutic failure in CoNS.
- PBP 2a is a conserved protein across staphylococcal species, suggesting a common resistance mechanism.
More Related Videos
Related Concept Videos
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Development of Antibiotic Resistance
Production of Antibiotics
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance

